Why is Trump doubling steel tariffs to 50%?
How will OPEC+ oil output hike impact prices?
Why is JPMorgan's Dimon warning about bond cracks?
What triggered Tesla's recent stock volatility?
How is AI threatening entry-level white collar jobs?
Why are American consumers still pessimistic on economy?
What caused leadership shake-up at ICE and deportations rise?
Summit Therapeutics, A Top 1% Biotech, Plummets On A High-Profile Failure
investors.com/news/technology/summit-therapeutics-stock-pd-1-vegf-bispecific-fails
Summit Therapeutics stock plunged Friday after its highly watched cancer drug failed to significantly improve overall survival.
The post Summit Therapeutics, A Top 1% Biotech, Plummets On A High-Profile Failure appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-05-30 13:22:19.